Serum cystatin C as an index of renal function in kidney transplant patients

Area of Science:

• Nephrology
• Transplant Medicine
• Biomarker Discovery

Background:

• Accurate measurement of renal function, specifically glomerular filtration rate (GFR), is crucial for managing renal transplant patients.
• Serum creatinine is the standard GFR marker, but its accuracy can be compromised by factors like muscle wasting and tubular secretion.

Purpose of the Study:

• To evaluate cystatin C and beta(2)-microglobulin (B(2)M) as reliable indicators of renal function in renal transplant recipients.
• To compare the efficacy of cystatin C and B(2)M against serum creatinine for GFR assessment.

Main Methods:

• Assessed renal function in 75 renal transplant patients using serum creatinine, cystatin C, and B(2)M.
• Correlated marker concentrations and analyzed GFR using established equations (MDRD, Cockroft-Gault).
• Utilized Receiver Operating Characteristic (ROC) analysis to quantify marker accuracy for detecting reduced GFR.

Main Results:

• Cystatin C and B(2)M showed significant correlations with creatinine.
• Serum creatinine demonstrated superior performance in GFR estimation equations compared to cystatin C and B(2)M.
• ROC analysis indicated serum creatinine was significantly more accurate than cystatin C in detecting reduced GFR.

Conclusions:

• Serum creatinine remains a more efficacious marker than serum cystatin C for assessing renal function in renal transplant patients.
• Despite correlations, cystatin C and B(2)M did not outperform creatinine in accurately reflecting GFR in this cohort.